FTC sues insulin middlemen, saying they pocket billions while patients face high costs

September 21, 2024

FTC sues insulin middlemen, saying they pocket billions while patients face high costs

This picture shows a unit dedicated to the production of insulin pens at the factory of the U.S. pharmaceutical company Eli Lilly in Fegersheim, France, on Oct. 12, 2015.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.

(Image credit: Frederick Florin)

from NPR Topics: News https://ift.tt/19yuYaS

Comments